J Pediatr Infect Dis 2011; 06(03): 211-216
DOI: 10.3233/JPI-2011-0315
Georg Thieme Verlag KG Stuttgart – New York

Use of corticosteroids in Mycoplasma pneumoniae encephalitis: A case report and review of literature

Tariq Saleh Al Fawaz
a   Pediatric Infectious Disease Section, Children's Hospital, King Fahad Medical City, Riyadh, Saudi Arabia
,
Sukesh Mohta
b   Pediatric Intensive Care Unit, Children's Hospital, King Fahad Medical City, Riyadh, Saudi Arabia
,
Jihad Nader Zahraa
b   Pediatric Intensive Care Unit, Children's Hospital, King Fahad Medical City, Riyadh, Saudi Arabia
› Institutsangaben

Verantwortlicher Herausgeber dieser Rubrik:
Weitere Informationen

Publikationsverlauf

13. Juni 2011

21. Juni 2011

Publikationsdatum:
28. Juli 2015 (online)

Abstract

Encephalitis is the most common central nervous system (CNS) complication of Mycoplasma pneumoniae infection. CNS involvement represents the second most common organ system involved other than respiratory system by M. pneumoniae. We report a case of 11-year old male child, who was referred to us with recurrent episodes of status epilepticus and worsening level of consciousness. M. pneumoniae encephalitis was diagnosed on the basis of positive serology and exclusion of other causes. High dose corticosteroid therapy was given, which resulted in rapid improvement in the patient's neurological condition and full recovery without any neurological sequel. This case emphasizes the importance of CNS complications of M. pneumoniae and shows that corticosteroid therapy has a place for treatment of mycoplasma encephalitis. The available literature regarding this subject is also presented.